Ibrahim Batal

Temporal Proteomic Assessment of Glomerular FAT1 in De Novo Membranous Nephropathy of the Kidney Allograft - Kidney International Reports kireports.org/article/S2468-… Good work here by @IbrahimBatal9 in collaboration with our Mayo proteomic core and @MayoClinicPath.

@fervenzafernan1 @SethiRenalPath @mvargas07 Happy birthday

@NadaAlachkar @AstridWeins Thank you Nada. Glad you liked the manuscript

Very nice work @IbrahimBatal9 @AstridWeins. congratulations! Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft sciencedirect.com/science/articl…

FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection doi.org/10.1016/j.kint… #kidneytransplant @MayoClinic @MayoClinicNeph @Inserm @CHLeMans @ColumbiaPath @ColumbiaMed @MPAlexanderMD @martacasalmoura

FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection. #MayoClinicKidney @SethiRenalPath @fervenzafernan1 kidney-international.org/article/S0085-….

Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse #podocytopathy in the #kidneyallograft doi.org/10.1016/j.kint… @harvardmed @ColumbiaPath @CHU_Lille @univ_lille @broadinstitute @ColumbiaKidney @ColumbiaMed @OHSUPathology #FSGS

@AstridWeins May he rest in peace

There is so much wisdom in this interview from 2020 with one of the greatest pathologists of all time. I turned to him many times for advice. What a loss for pathologists, clinicians and patients. We will miss you, Chris Fletcher! 😢 thepathologist.com/outside-the-la…

@LVRiella Beautiful

Incredible talent!!!

@LVRiella Well deserved

I was honored to receive the 2024 American Society of Transplantation Basic Science Investigator Award at #ATC2024Philly With gratitude to mentors, trainees, collaborators and the AST. 🙏

@FridaRosenblum @sam_albadri There is no magic time. Typically a few daybut depending on the injury and sloughing of the endothelium thrombi can persist for longer especially if patient on CNI. Early AMR would be less favored of DSA is negative pretransplant and C4d is neg. Important to rule out ongoing TMA

@sam_albadri @IbrahimBatal9

In deceased donor kidneys with head trauma and fibrin thrombi, what is the timeline for them to disappear/wash out? What if you see endothelial swelling and other features of TMA PO day 6? Is that donor derived or early AMR? @VineetaKumar8 @JeanHouMD @AstridWeins @SethiRenalPath

1/6 Thankful to @timucin_taner @MayoTransplant @amjtransplant Sharing our pre-proof, pre-print manuscript Using Imaging Mass Cytometry. Novel #singlecell #Spatialtechnology #machinelearning #ArtificalIntelligence #Precisionmedicine authors.elsevier.com/sd/article/S16…

Kidney Pathology Certificate Program Starting January 2023 pre-register at my.glomcon.org

@AlcinoGama @ASNKidney @theglasspusher Congratulations 🍾

So proud of my great friend and colleague @IbrahimBatal9 from whom we can explain nothing but great things. Congratulations 🎉🎊🍾 and best wishes as you study "The Immunopathology of Donor-Derived APOL1 Nephropathy"

Extremely honored to receive this year precision medicine award

@jradnephro @KIReports Congratulations

Happy to announce KI Reports Impact Factor for 2022: 6.234! A big thank you to our authors, reviewers and the editorial team! @KIReports

@WCMCPathology Congratulations

Please join us in congratulating Dr. Surya Seshan for earning the Peter Paul Rosen Clinical Service Award for outstanding achievement in either Anatomic or Clinical #Pathology, named after Dr. Peter Rosen, who rendered distinguished and meritorious service to #WCM!

@NKF_NephPros @SumitMohanMD Congratulations

Congratulations to @SumitMohanMD, recipient of the 2022 Excellence in Kidney Transplantation Award! This award recognizes those whose exceptional research has contributed novel insights to improved access to kidney transplantation. #NKFClinicals

@RajguptaEM Interestingly we found that glomerulitis and high proteinuria are associated with worse prognosis in primary MN in the allograft (your pt have both plus low albumin). The glomerulitis in this case may not reflect AMR but stasis and may need to rule out renal vein thrombosis

ESRD from HTN, DDRT >5 yrs back, presenting with new-onset nephrotic proteinuria. PLA2R+ (IF & serum). C4d-, DSA-. Several gloms show glomerulitis, doubl contours and mild mesangiolysis, ptc1. Is this de novo MN some form of unusual CA-AMR, or unrelated to Tx? #askrenalpath

@RajguptaEM Although no one will know for sure my impression is that AMR associated MGN is weak here for a few reasons: PLA2r is pos, DSA neg, C4d neg and ptc0-1 (none of these reasons by itself is definitive but the combination argues against this possibility). It is likely primary MN